Outschoorn I M
Immunology. 1983 Mar;48(3):597-603.
Rabbits were immunized with purified antidextran containing IgG2. Half of the animals were treated with commercial human IgG intravenously to induce tolerance. The antisera were absorbed and/or eluted from IgG-Sepharose columns and the antibodies tested with a panel of at least eight human myeloma proteins of the four IgG subclasses, both kappa and lambda types. All animals produced mainly anti-IgG2 or IgG4, sometimes intechanged between these maxima or between kappa and lambda types over a series of bleedings. Absorption with IgG2 and/or IgG4 myeloma proteins resulted in sera or antibody preparations specific for the IgG1 or IgG3 subclasses, and the amount of those antibodies also varied between bleedings from the same animal. It may be concluded that anti-IgG2 and anti-IgG4 syntheses are related in a complementary manner or are equally likely to be produced in a response to IgG2; while IgG1 and IgG3 are also interrelated, but with an inverse relationship to IgG2 and IgG4. Alternatively anti-IgG2 and anti-IgG4 antibodies could be highly cross-reactive, and so could anti-IgG1 and anti-IgG3 antibodies.
用含有IgG2的纯化抗右旋糖酐对兔子进行免疫。一半动物静脉注射商业人IgG以诱导耐受。抗血清从IgG-琼脂糖柱上吸收和/或洗脱,并用一组至少八种四种IgG亚类的人骨髓瘤蛋白(kappa和lambda型)检测抗体。所有动物主要产生抗IgG2或抗IgG4,有时在一系列采血过程中,这些最大值之间或kappa和lambda型之间会相互转换。用IgG2和/或IgG4骨髓瘤蛋白吸收后,得到针对IgG1或IgG3亚类的血清或抗体制剂,同一动物不同采血的这些抗体量也有所不同。可以得出结论,抗IgG2和抗IgG4的合成以互补方式相关,或者在对IgG2的反应中同样可能产生;而IgG1和IgG3也相互关联,但与IgG2和IgG4呈反比关系。或者,抗IgG2和抗IgG4抗体可能具有高度交叉反应性,抗IgG1和抗IgG3抗体也可能如此。